RT @UmarHayat216: Excited to share new publication. CRISPR/Cas9 genome editing technology for fatty liver. A new era of genetic engineerin…
20 followers
1,798 followers
REVIEW "Genome Editing in Dyslipidemia and Atherosclerosis" Chen Z et al. Adv Exp Med Biol. 2022-12-02. https://t.co/xJepmOd3de We point to the challenges in maximizing efficacy and minimizing safety issues related to the once-and-done therapy focusing
10,959 followers
RT @UmarHayat216: Excited to share new publication. CRISPR/Cas9 genome editing technology for fatty liver. A new era of genetic engineerin…
556 followers
Which challenges and opportunities does the CRISPR-Cas toolbox offers and which delivery obstacles need to be faced for successful clinical translation? @CirculatHealth @RMUtrecht @nazmailahibaks @VaderPieter https://t.co/bGyJevsojd